Rising Premature Birth Rates Fuel Growth In The Market Driver: Leading Transformation in the Neonatal Respiratory Distress Syndrome Treatment Market in 2025

What Are the Projected Growth and Market Size Trends for the Neonatal Respiratory Distress Syndrome Treatment Market?
In recent years, the market size for neonatal respiratory distress syndrome treatment has witnessed a robust growth. Projected to escalate from a value of $0.96 billion in 2024 to $1.03 billion in 2025, this market will adopt a compound annual growth rate (CAGR) of 8.3%. The growth observed in the historical period can be credited to factors such as rising permeability and accumulation of fluid within the alveoli, augmented alveolar-capillary permeability, increased use of mechanical ventilation, heightening awareness of neonatal care among healthcare providers and parents, and surge in healthcare investments.

The market size for treating neonatal respiratory distress syndrome is projected to witness significant growth in the next several years. It is set to reach $1.41 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.0%. This growth during the forecast period can be tied to the increased preference for accessories and consumables, escalating NICU admissions, a rising demand for personalized medicine, the surge in premature births, and enhanced research and development activities. Notable trends during the forecast period include the automation in neonatal intensive care units (NICUs), the inclusion of artificial intelligence (AI), technological progression in neonatal care, innovation in surfactant therapy, and advancements in ventilator technologies.

What Is Driving the Growth Trajectory of the Neonatal Respiratory Distress Syndrome Treatment Market?
The neonatal respiratory distress syndrome treatment market's growth is anticipated to be fueled by an increase in premature births. Preterm births, which are births that occur before the 37th week of pregnancy, present the harshest health risks to babies born before the 32nd week as a regular pregnancy endures approximately 40 weeks. A surge in premature births is being observed due to various factors such as the mother's older age, multiple pregnancies, existing health conditions, lifestyle behaviors, utilization of fertility treatments, infections, and external environmental influences. Neonatal respiratory distress syndrome (NRDS) treatment is often required for prematurely born babies because their lungs are underdeveloped and the production of surfactant is insufficient. This treatment enhances lung functionality, stabilizes breathing, and lessens the chance of respiratory failure in prematurely born infants. For example, data from Tommy's, a British charity organization, reported that the percentage of live premature births in England and Wales rose to 7.9% in 2022 from 7.5% in 2021. This represents the second successive annual increase in premature births, with over 53,000 babies born prematurely in 2022. As a result, the increased occurrence of premature births is propelling the evolution of the neonatal respiratory distress syndrome treatment market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp

Which Leading Companies Are Shaping the Growth of the Neonatal Respiratory Distress Syndrome Treatment Market?
Major companies operating in the neonatal respiratory distress syndrome treatment market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., Lyomark Pharma GmbH

What Are the Major Trends Shaping the Neonatal Respiratory Distress Syndrome Treatment Market?
Key players in the neonatal respiratory distress syndrome treatment market are focusing on the development of advanced technologies such as nitric oxide generators. These innovative devices are designed to improve oxygenation, reduce respiratory complications, and provide non-invasive treatment options for newborn babies suffering from hypoxic respiratory failure. Nitric oxide generators are medical devices that produce and deliver nitric oxide gas, a popular method for treating respiratory problems. They work by enhancing oxygenation and relieving pulmonary hypertension, especially in newborns and severely ill patients. For instance, in June 2022, Beyond Air Inc., a US-based firm specializing in medical devices and biopharmaceuticals, obtained FDA clearance for LungFit PH. This cutting-edge nitric oxide generator is intended to treat full-term and near-term newborns with hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). The device employs Beyond Air's patented Ionizer technology to create nitric oxide from the surrounding air on demand, ensuring a limitless supply devoid of dosage or flow concerns. It also features a low-power compressor that ionizes nitrogen and oxygen, thereby reducing nitrogen dioxide (NO2) production, which is subsequently safely eliminated via a smart filter.

What Are the Key Segments of the Neonatal Respiratory Distress Syndrome Treatment Market?
The neonatal respiratory distress syndrome treatment market covered in this report is segmented -

1) By Therapy: Oxygen Therapy, Surfactant Therapy
2) By Route Of Administration: Parenteral, Inhalation, Other Routes Of Administration
3) By End User: Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies

Subsegments:
1) By Oxygen Therapy: Conventional Oxygen Therapy, High-Flow Nasal Cannula (HFNC) Oxygen Therapy, Continuous Positive Airway Pressure (CPAP) Oxygen Therapy, Invasive Mechanical Ventilation With Oxygen Therapy
2) By Surfactant Therapy: Natural Surfactants, Synthetic Surfactants, Combined Surfactant Therapy (Natural + Synthetic), Prophylactic Surfactant Therapy, Rescue Surfactant Therapy

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/neonatal-respiratory-distress-syndrome-treatment-global-market-report

Which Region Dominates the Neonatal Respiratory Distress Syndrome Treatment Market?
North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Neonatal Respiratory Distress Syndrome Treatment Global Market Report?

- Market Size Analysis: Analyze the neonatal respiratory distress syndrome treatment Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the neonatal respiratory distress syndrome treatment Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall neonatal respiratory distress syndrome treatment market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the neonatal respiratory distress syndrome treatment market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20899

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.